Allosteric activation of the co-receptor BAK1 by the EFR receptor kinase initiates immune signaling
eLife · 19.07.2024 · 12
DOI: 10.7554/elife.92110 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, online erschienen am 19.07.2024. Verfasst von Henning Mühlenbeck und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Plant and Microbial Biology, Zürich-Basel Plant Science Center, University of Zürich, Zürich, Switzerland. Hauptthemen laut MEDLINE: Protein Serine-Threonine Kinases, Signal Transduction, Arabidopsis Proteins, Arabidopsis. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, UK Research and Innovation.
Abstract (Originalsprache)
Transmembrane signaling by plant receptor kinases (RKs) has long been thought to involve reciprocal trans-phosphorylation of their intracellular kinase domains. The fact that many of these are pseudokinase domains, however, suggests that additional mechanisms must govern RK signaling activation. Non-catalytic signaling mechanisms of protein kinase domains have been described in metazoans, but information is scarce for plants. Recently, a non-catalytic function was reported for the leucine-rich repeat (LRR)-RK subfamily XIIa member EFR (elongation factor Tu receptor) and phosphorylation-dependent conformational changes were proposed to regulate signaling of RKs with non-RD kinase domains. Here, using EFR as a model, we describe a non-catalytic activation mechanism for LRR-RKs with non-RD kinase domains. EFR is an active kinase, but a kinase-dead variant retains the ability to enhance catalytic activity of its co-receptor kinase BAK1/SERK3 (brassinosteroid insensitive 1-associated kinase 1/somatic embryogenesis receptor kinase 3). Applying hydrogen-deuterium exchange mass spectrometry (HDX-MS) analysis and designing homology-based intragenic suppressor mutations, we provide evidence that the EFR kinase domain must adopt its active conformation in order to activate BAK1 allosterically, likely by supporting αC-helix positioning in BAK1. Our results suggest a conformational toggle model for signaling, in which BAK1 first phosphorylates EFR in the activation loop to stabilize its active conformation, allowing EFR in turn to allosterically activate BAK1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Plant and Microbial Biology, Zürich-Basel Plant Science Center, University of Zürich, Zürich, Switzerland.
- Department of Pharmacology, Yale University School of Medicine, New Haven, United States.
- Yale Cancer Biology Institute, Yale University West Campus, West Haven, United States.
- The Sainsbury Laboratory, University of East Anglia, Norwich Research Park, Norwich, United Kingdom.
ORCID-Profile: Kyle W Bender, Cyril Zipfel
Förderung
- NIGMS NIH HHS
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- UK Research and Innovation
- National Institute of General Medical Sciences
Zitieren
APA
Mühlenbeck, H., Tsutsui, Y., Lemmon, M. A., Bender, K. W., & Zipfel, C. (2024). Allosteric activation of the co-receptor BAK1 by the EFR receptor kinase initiates immune signaling. eLife, 12. https://doi.org/10.7554/elife.92110
Vancouver
Mühlenbeck H, Tsutsui Y, Lemmon MA, Bender KW, Zipfel C. Allosteric activation of the co-receptor BAK1 by the EFR receptor kinase initiates immune signaling. eLife. 2024;12. doi:10.7554/elife.92110
BibTeX
@article{Mhlenbeck2024,
author = {Mühlenbeck, Henning and Tsutsui, Yuko and Lemmon, Mark A and Bender, Kyle W and Zipfel, Cyril},
title = {Allosteric activation of the co-receptor BAK1 by the EFR receptor kinase initiates immune signaling},
journal = {eLife},
year = {2024},
volume = {12},
doi = {10.7554/elife.92110}
}
EUVIMED